Search
for
Sort by
Research 721–750 of 1000+
- 566 Staphylococcus epidermidis for the topical treatment of epidermal growth factor receptor (EGFR) inhibitor-induced dermal toxicity
- 661 Recombinant human TSG-6 ameliorates delayed wound healing in mice with diet induced diabetes
- Role of Dermal Factors Involved in Regulating the Melanin and Melanogenesis of Mammalian Melanocytes in Normal and Abnormal Skin
- Elevation of circulating DNAs of disease-associated cytokines in serum cell-free DNA from patients with alopecia areata
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Ophiasis Alopecia Areata in a Patient With Spondyloarthritis on Secukinumab: A Case Report and Review of the Literature
- current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
- β-Nicotinamide Mononucleotide Promotes Cell Proliferation and Hair Growth by Reducing Oxidative Stress
- Cutaneous Manifestations in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED): A Comprehensive Review
- Editors’ Picks
- Features of the immune status and comorbidities in children with alopecia areata
- 22 Biological functions of exosome-like nanoparticles isolated from rose (rosa damascena) stem cell culture (RSCE)
- 20 Exosomes derived from adipose tissue-derived mesenchymal stem cells (ASCE) for the treatment of dupilumab-related facial redness in patients with atopic dermatitis
- 24 ARQ-234: a high affinity CD200-Fc fusion protein for the treatment of atopic dermatitis
- Medicom Conference Report WCD 2023
- Serum Interleukin 17 in Patients with Pattern Hair Loss
- BH14 Multiple sclerosis and alopecia areata: drug-induced alopecia areata or coexisting autoimmune phenomena?
- ISID1494 - Dual effects of HA-iMSC-exosomes in human follicle dermal papilla cells (HFDPC) on androgenic alopecia in vitro model.
- CD4+ Treg expansion arrests disease progression in a pre-clinical model of alopecia areata
- 877 Loss of UBE2N in keratinocytes leads to skin inflammation and immune infiltration through IRAK1/4-mediated processes
- 219 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid
- 1497 Type 2-mediated oxidative reprogramming promotes the transition of macrophages into repair mode and is required for wound healing
- 1326 Translation-dependent skin hyperplasia is promoted by type 1/17 inflammation in psoriasis
- 056 IKZF1 and IKAROS overexpression contributes to the pathogenesis of alopecia areata
- 1396 Interferon-24 regulates the expression of MMP1 and dermal collagen of the skin
- 1117 PX-12 inhibits NLRP3 inflammasome activation to treat psoriasis
- 361 p120-catenin regulates epidermal inflammation in a cadherin-dependent manner
- 1617 Impact of type 2 cytokines on the keratinocytes-s. aureus interaction
- 1375 Effects of a new recombinant human collagen on skin aging
- 224 Humoral immune response to COVID-19 vaccination in psoriasis patients on biologic therapy is impaired compared to healthy controls